Skip to content
RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION · INFORMATIONAL MATERIAL
VLS retatrutide 40 mg pen next to its box, in a photographic studio with a red DNA background
AvailablePenGLP‑1 · GIP · glucagon

Retatrutide 40 mg · multi-dose pen

The pen holds 40 mg of retatrutide in 3 mL of solution. The solution arrives ready from the factory, so the person prepares nothing: they fit a new needle, select the setting in the window and follow the guidance of their healthcare professional.

  • PrefilledThe solution is filled at the plant. There is no powder and no separate diluent.
  • Fixed concentration40 mg in 3 mL: 13.33 mg per millilitre, the same in every unit.
  • Reading in the windowThe pen’s window shows the selected setting.
  • VerifiableBatch number, seal and verification code on the box.

Specifications

Active ingredientRetatrutide
Concentration40 mg in 3 mL · 13.33 mg per mL
PresentationPrefilled multi-dose pen
Route stated on the labelSubcutaneous
Needles included4 of 3.0 mm
StorageRefrigerated, between 2 and 8 °C
Shelf life stated by the manufacturer24 months

Data taken from the manufacturer’s label and packaging.

What is in the box

  • 1 multi-dose retatrutide pen, 40 mg / 3 mL
  • 4 subcutaneous needles of 3.0 mm
  • Batch number and expiry date printed on the box
  • Security seal and verification code

Three receptors, one molecule

Retatrutide is a peptide designed to activate three receptors at once. Adding the glucagon receptor to those of GLP‑1 and GIP is what sets it apart from earlier analogues.

GLP‑1Takes part in the satiety signal and in glucose-dependent insulin release.
GIPActs on glucose and lipid metabolism and complements GLP‑1.
GlucagonIs linked to energy expenditure and to the use of fats.

Trial results are averages for groups of participants and do not predict what will happen to an individual. What is right for each case is decided by a healthcare professional.

Research briefing

The full research briefing

The science behind retatrutide and the multi-dose pen, explained in detail in a separate briefing. Opens in a new tab.

Open the briefing (in Spanish)
View certificates

Certificate of analysis

Ask for the certificate of the batch shown on your box, or see the published active-ingredient certificate (batch R20260318).

Retatrutide · COA · active ingredientBatch R20260318 · Purity 99.38% · produced 18 Mar 2026

Want more information about the pen?

Message us on WhatsApp and we will reply about availability, batches and delivery.